Resultats de la cerca - Michael D. Curley

  • Mostrar 1 - 5 resultats de 5
Refinar resultats
  1. 1
    Mammalian Target of Rapamycin Is a Therapeutic Target for Murine Ovarian Endometrioid Adenocarcinomas with Dysregulated Wnt/β-Catenin and PTEN

    Mammalian Target of Rapamycin Is a Therapeutic Target for Murine Ovarian Endometrioid Adenocarcinomas with Dysregulated Wnt/β-Catenin and PTEN per Pradeep S. Tanwar, LiHua Zhang, Tomoko Kaneko-Tarui, Michael D. Curley, Makoto M. Taketo, Poonam Rani, Drucilla J. Roberts, Jose M. Teixeira

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells

    Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells per Anne M. Friel, Lingling Zhang, Michael D. Curley, Vanessa A. Therrien, Petra Sergent, Sarah E Belden, Darrell R. Borger, Gayatry Mohapatra, Lawrence Zukerberg, Rosemary Foster, Bo R. Rueda

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer

    CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer per Michael D. Curley, Vanessa A. Therrien, Christine L. Cummings, Petra Sergent, Carolyn R. Koulouris, Anne M. Friel, Drucilla J. Roberts, Michael V. Seiden, David T. Scadden, Bo R. Rueda, Rosemary Foster

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model

    Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model per Christopher McCann, Whitfield B. Growdon, Kashmira Kulkarni‐Datar, Michael D. Curley, Anne M. Friel, Jennifer Proctor, Hana Sheikh, Igor V. Deyneko, Jeanne A. Ferguson, Vinod Vathipadiekal, Michael J. Birrer, Darrell R. Borger, Gayatry Mohapatra, Lawrence Zukerberg, Rosemary Foster, John R. MacDougall, Bo R. Rueda

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer

    Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer per Adam J. Camblin, Emily A. Pace, Sharlene Adams, Michael D. Curley, Victoria Rimkunas, Lin Nie, Gege Tan, Troy Bloom, Sergio Iadevaia, Jason Baum, Charlene Minx, Akos Czibere, Chrystal U. Louis, Daryl C. Drummond, Ulrik B. Nielsen, Birgit Schoeberl, J. Marc Pipas, Robert M. Straubinger, Vasileios Askoxylakis, Alexey A. Lugovskoy

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: